Fuan Pharmaceutical (Group) Co Ltd Class A 300194
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥4.18
- Day Range
- ¥4.23–4.81
- 52-Week Range
- ¥2.92–5.15
- Bid/Ask
- ¥4.75 / ¥4.76
- Market Cap
- ¥5.65 Bil
- Volume/Avg
- 92.8 Mil / 21.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 19.25
- Price/Sales
- 2.15
- Dividend Yield (Trailing)
- 1.05%
- Dividend Yield (Forward)
- 1.05%
- Total Yield
- 1.05%
Company Profile
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,292
- Website
- http://www.fapharm.com
Comparables
Valuation
|
Metric
|
300194
|
600594
|
603367
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.25 | — | 14.47 |
Price/Book Value | 1.31 | 1.11 | 1.12 |
Price/Sales | 2.15 | 1.20 | 1.51 |
Price/Cash Flow | 12.46 | 14.04 | 7.52 |
Price/Earnings
300194
600594
603367
Financial Strength
|
Metric
|
300194
|
600594
|
603367
|
|---|---|---|---|
Quick Ratio | 0.99 | 1.21 | 2.65 |
Current Ratio | 1.59 | 1.82 | 3.56 |
Interest Coverage | 12.64 | −3.36 | 90.13 |
Quick Ratio
300194
600594
603367
Profitability
|
Metric
|
300194
|
600594
|
603367
|
|---|---|---|---|
Return on Assets (Normalized) | 1.26% | −3.17% | 6.00% |
Return on Equity (Normalized) | 1.84% | −5.06% | 7.61% |
Return on Invested Capital (Normalized) | 1.44% | −3.17% | 6.84% |
Return on Assets
300194
600594
603367
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Ksqfsmxhh | Nltk | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Cjnfnxddk | Pympv | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Vrtjrnwf | Kjv | $46.6 Bil | |||
| Viatris Inc
VTRS
| Xyyhbqmf | Hwbwq | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Vjlfpnkt | Vlpgh | $13.2 Bil | |||
| Catalent Inc
CTLT
| Ctgmykyxs | Dvnyrv | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Dkzyptbh | Wxgzdc | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Tjmdmltq | Qkxxs | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Pfrkqplr | Fpw | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Kmdrwzsq | Vtxtv | $2.2 Bil |
United States